SYNERGY CHC CORP (SNYR) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SNYR • US87165D2080

1.73 USD
-0.04 (-2.26%)
Last: Feb 9, 2026, 04:32 PM
Fundamental Rating

4

SNYR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 36 industry peers in the Personal Care Products industry. Both the profitability and the financial health of SNYR get a neutral evaluation. Nothing too spectacular is happening here. SNYR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • SNYR had positive earnings in the past year.
  • In the past year SNYR has reported a negative cash flow from operations.
SNYR Yearly Net Income VS EBIT VS OCF VS FCFSNYR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2023 2024 0 5M -5M 10M

1.2 Ratios

  • SNYR's Return On Assets of 12.47% is amongst the best of the industry. SNYR outperforms 88.89% of its industry peers.
  • SNYR has a better Return On Invested Capital (29.10%) than 97.22% of its industry peers.
Industry RankSector Rank
ROA 12.47%
ROE N/A
ROIC 29.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNYR Yearly ROA, ROE, ROICSNYR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2023 2024 0 500 1K 1.5K 2K 2.5K

1.3 Margins

  • SNYR's Profit Margin of 7.46% is fine compared to the rest of the industry. SNYR outperforms 77.78% of its industry peers.
  • SNYR's Operating Margin of 17.95% is amongst the best of the industry. SNYR outperforms 91.67% of its industry peers.
  • SNYR's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 71.08%, SNYR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SNYR has remained more or less at the same level.
Industry RankSector Rank
OM 17.95%
PM (TTM) 7.46%
GM 71.08%
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
SNYR Yearly Profit, Operating, Gross MarginsSNYR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2023 2024 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNYR is creating value.
  • The number of shares outstanding for SNYR has been increased compared to 1 year ago.
  • The number of shares outstanding for SNYR has been increased compared to 5 years ago.
  • SNYR has a better debt/assets ratio than last year.
SNYR Yearly Shares OutstandingSNYR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2023 2024 20M 40M 60M 80M
SNYR Yearly Total Debt VS Total AssetsSNYR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of 1.23, we must say that SNYR is in the distress zone and has some risk of bankruptcy.
  • SNYR's Altman-Z score of 1.23 is on the low side compared to the rest of the industry. SNYR is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.23
ROIC/WACC2.63
WACC11.07%
SNYR Yearly LT Debt VS Equity VS FCFSNYR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

  • SNYR has a Current Ratio of 5.35. This indicates that SNYR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.35, SNYR belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
  • SNYR has a Quick Ratio of 4.79. This indicates that SNYR is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of SNYR (4.79) is better than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 5.35
Quick Ratio 4.79
SNYR Yearly Current Assets VS Current LiabilitesSNYR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2023 2024 5M 10M 15M

4

3. Growth

3.1 Past

  • The earnings per share for SNYR have decreased strongly by -67.60% in the last year.
  • SNYR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.57%.
  • SNYR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.48% yearly.
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.04%
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%12.4%

3.2 Future

  • SNYR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.84% yearly.
  • The Revenue is expected to grow by 19.96% on average over the next years. This is quite good.
EPS Next Y-25%
EPS Next 2Y-7.2%
EPS Next 3Y28.84%
EPS Next 5YN/A
Revenue Next Year0.72%
Revenue Next 2Y24.29%
Revenue Next 3Y19.96%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNYR Yearly Revenue VS EstimatesSNYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2023 2024 2025 2026 2027 20M 40M 60M
SNYR Yearly EPS VS EstimatesSNYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.97, which indicates a rather cheap valuation of SNYR.
  • Compared to the rest of the industry, the Price/Earnings ratio of SNYR indicates a rather cheap valuation: SNYR is cheaper than 100.00% of the companies listed in the same industry.
  • SNYR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
  • A Price/Forward Earnings ratio of 5.47 indicates a rather cheap valuation of SNYR.
  • SNYR's Price/Forward Earnings ratio is rather cheap when compared to the industry. SNYR is cheaper than 94.44% of the companies in the same industry.
  • SNYR is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.97
Fwd PE 5.47
SNYR Price Earnings VS Forward Price EarningsSNYR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • SNYR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SNYR is cheaper than 80.56% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.05
SNYR Per share dataSNYR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SNYR's earnings are expected to grow with 28.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.2%
EPS Next 3Y28.84%

0

5. Dividend

5.1 Amount

  • No dividends for SNYR!.
Industry RankSector Rank
Dividend Yield 0%

SYNERGY CHC CORP

NASDAQ:SNYR (2/9/2026, 4:32:22 PM)

1.73

-0.04 (-2.26%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners14.58%
Inst Owner ChangeN/A
Ins Owners6.97%
Ins Owner Change0%
Market Cap19.46M
Revenue(TTM)34.59M
Net Income(TTM)2.58M
Analysts82.86
Price Target7.14 (312.72%)
Short Float %0.19%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)53.19%
Min EPS beat(2)-1.96%
Max EPS beat(2)108.33%
EPS beat(4)2
Avg EPS beat(4)14.06%
Min EPS beat(4)-90.2%
Max EPS beat(4)108.33%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-27.06%
Min Revenue beat(2)-27.95%
Max Revenue beat(2)-26.16%
Revenue beat(4)0
Avg Revenue beat(4)-17.48%
Min Revenue beat(4)-27.95%
Max Revenue beat(4)-4.54%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-30%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-92.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-34.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-18.14%
Valuation
Industry RankSector Rank
PE 5.97
Fwd PE 5.47
P/S 0.56
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.05
EPS(TTM)0.29
EY16.76%
EPS(NY)0.32
Fwd EY18.28%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS3.07
BVpS-0.73
TBVpS-0.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 12.47%
ROE N/A
ROCE 36.83%
ROIC 29.1%
ROICexc 30.97%
ROICexgc 31.33%
OM 17.95%
PM (TTM) 7.46%
GM 71.08%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y22.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-0.29%
F-Score3
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.02
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.88
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.35
Quick Ratio 4.79
Altman-Z 1.23
F-Score3
WACC11.07%
ROIC/WACC2.63
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.04%
EPS Next Y-25%
EPS Next 2Y-7.2%
EPS Next 3Y28.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.57%
Revenue growth 3YN/A
Revenue growth 5Y3.48%
Sales Q2Q%12.4%
Revenue Next Year0.72%
Revenue Next 2Y24.29%
Revenue Next 3Y19.96%
Revenue Next 5YN/A
EBIT growth 1Y-46.32%
EBIT growth 3YN/A
EBIT growth 5Y26.96%
EBIT Next Year47.57%
EBIT Next 3Y33.07%
EBIT Next 5YN/A
FCF growth 1Y-1239.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1239.06%
OCF growth 3YN/A
OCF growth 5YN/A

SYNERGY CHC CORP / SNYR FAQ

Can you provide the ChartMill fundamental rating for SYNERGY CHC CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SNYR.


What is the valuation status of SYNERGY CHC CORP (SNYR) stock?

ChartMill assigns a valuation rating of 6 / 10 to SYNERGY CHC CORP (SNYR). This can be considered as Fairly Valued.


What is the profitability of SNYR stock?

SYNERGY CHC CORP (SNYR) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SYNERGY CHC CORP (SNYR) stock?

The Price/Earnings (PE) ratio for SYNERGY CHC CORP (SNYR) is 5.97 and the Price/Book (PB) ratio is -2.36.


How financially healthy is SYNERGY CHC CORP?

The financial health rating of SYNERGY CHC CORP (SNYR) is 4 / 10.